Streetbeat News

Partnerships

NSANY

TSLA

Republican Congressman Jason Smith has raised concerns about Tesla's relationship with its Chinese battery supplier, Contemporary Amperex Technology Ltd (CATL), amid worries that U.S. electric vehicle subsidies could be funneled to overseas entities. Smith has asked Tesla CEO Elon Musk for confirmation about the company's current and future contracts with CATL. The concerns stem from CATL's potential agreements similar to its existing one with Ford, which is under investigation by Republican lawmakers.

Portfolio Pulse from Benzinga Neuro

September 20, 2023 | 5:31 am

HTZ

TSLA

Tesla Inc (NASDAQ:TSLA) has announced that all its cars rented by Hertz Global Holdings Inc (NASDAQ:HTZ) in the U.S. will now have access to Tesla app. The app allows users to use keyless lock/unlock via phone key, remotely precondition the cabin, or track charge status. This move is seen as a way to enhance the EV experience for Hertz rental customers and build brand loyalty.

Portfolio Pulse from Anan Ashraf

September 20, 2023 | 4:51 am

F

Ford Motor Co. has reached a preliminary labor agreement with Unifor, the Canadian labor union, avoiding a potential second strike. The agreement will affect approximately 5,600 members at Ford’s Canadian facilities. The details of the agreement remain undisclosed. Unifor had been advocating for better pensions, higher wages, and support for workers as Ford transitions to electric vehicle manufacturing.

Portfolio Pulse from Benzinga Neuro

September 20, 2023 | 4:21 am

TSLA

CS Energy has unveiled a timelapse video of its $150 million Tesla Megapack project under construction in Queensland, Australia. The Megapack, launched in 2019, has become a preferred choice for utility-scale energy storage projects, boosting Tesla's energy storage capacity by 222% yearly. CS Energy's Chinchilla Battery system, which features a 200 MWh Megapack system, is a significant contributor to the Megapack's growth. The project is expected to enhance the state's use of renewable energy and stabilize the grid, with completion anticipated by the end of 2023.

Portfolio Pulse from Benzinga Neuro

September 20, 2023 | 3:12 am

FOXO

Foxo Technologies has entered into a shares for services agreement with Mitchell Silberberg & Knupp (MSK). Under the agreement, Foxo issued 2,928,662 shares and rights to receive 5,110,263 shares of Class A common stock to MSK.

Portfolio Pulse from Charles Gross

September 19, 2023 | 9:32 pm

MAPS

WM Technology, Inc. (NASDAQ:MAPS), also known as Weedmaps, is partnering with Abstrax, a pioneer in botanical flavor technology, to conduct research on cannabis. The collaboration aims to deepen consumer understanding of cannabis and will showcase new exotic cannabis compounds. Ahead of Tuesday's market close, MAPS shares saw a decline of 2.25%, trading at $1.52 per share.

Portfolio Pulse from Joana Scopel

September 19, 2023 | 8:44 pm

SLGC

SomaLogic, a US-based biotech company, has partnered with Korea's DNA Link to bring its 7,000-Plex SomaScan platform to the rapidly growing Asia-Pacific proteomics market. The partnership aims to leverage DNA Link's extensive network in the region to expand the reach of SomaLogic's proteomics technology.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 8:31 pm

BXP

Enel North America has signed a power purchase agreement with BXP, the largest publicly traded developer, owner, and manager of premier workplaces in the United States, for a 21-megawatt portion of the Estonian solar project under construction in Texas. The 202 MW solar project, paired with a 104 MW battery system, is expected to come online in late 2024. The agreement builds on a longstanding relationship between Enel and BXP for advanced energy solutions.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 8:17 pm

LCFY

Locafy has announced an enterprise partnership with Method. The details of the partnership were not disclosed in the article.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 8:13 pm

INBX

Inhibrx has announced that Chiesi Farmaceutici S.p.A has declined to exercise its option for ex-North America rights to develop and commercialise INBRX-101.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 8:01 pm